Teradyne, Inc. Forecast, price target & analysts
Teradyne, Inc. Target price 2026 - Analyst rating & recommendation
Teradyne, Inc. Classifications & Recommendation
Teradyne, Inc. Price Target
| Target Price | $428.40 |
| Price | $398.38 |
| Potential | 7.54% |
| Number of Estimates | 18 |
| 18 Analysts have issued a price target Teradyne, Inc. 2027 . The average Teradyne, Inc. target price is $428.40. This is 7.54% higher than the current stock price. The highest price target is $577.50 44.96% , the lowest is $272.70 31.55% . | |
| A rating was issued by 22 analysts: 16 Analysts recommend Teradyne, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Teradyne, Inc. stock has an average upside potential 2027 of 7.54% . Most analysts recommend the Teradyne, Inc. stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
20 Analysts have issued a sales forecast Teradyne, Inc. 2026 . The average Teradyne, Inc. sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Teradyne, Inc. EBITDA forecast 2026. The average Teradyne, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Teradyne, Inc. Analysts have issued a net profit forecast 2026. The average Teradyne, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
20 Analysts have issued a Teradyne, Inc. forecast for earnings per share. The average Teradyne, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current Teradyne, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Outperform
➜
Neutral
|
Downgrade | Aug 21 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 30 2026 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Jul 30 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jul 20 2026 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jul 06 2026 |
| Susquehanna |
Positive
➜
Positive
|
Unchanged | Jun 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Baird:
Outperform
➜
Neutral
|
Aug 21 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Jul 30 2026 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Jul 30 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Jul 29 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jul 20 2026 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jul 06 2026 |
|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Jun 30 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
